InsidersTradesSigma
Track the Senzime AB share price and the full management transaction log of the company, a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Senzime AB has recorded 0 insider filings. Market capitalisation: €578.6m. Every trade is accessible without an account.
Analysts rate Senzime AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 10.50.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Senzime AB is a company focused on developing patient monitoring solutions in the healthcare sector. It is listed on the XSTO stock exchange.